Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MET-097i
MET-097i
3 trial readouts that could shake up the obesity market this year
Pharma Voice
Wed, 01/8/25 - 11:15 am
obesity
weight loss
Metsera
MET-097i
Skye Bioscience
nimacimab
Eli Lilly
orforglipron
clinical trials
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Fierce Biotech
Tue, 01/7/25 - 06:57 pm
Metsera
GLP-1 agonist
weight loss
MET-097i